GOLDMAN SACHS GROUP INC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 50 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$1,921,000
+332.7%
257,857
+302.9%
0.00%
Q4 2016$444,000
-24.9%
64,006
-10.8%
0.00%
Q3 2016$591,000
-80.9%
71,750
-81.2%
0.00%
-100.0%
Q2 2016$3,093,000
+31.3%
381,851
-17.7%
0.00%0.0%
Q1 2016$2,356,000
+1277.8%
463,764
+1994.3%
0.00%
Q4 2015$171,000
+55.5%
22,144
+16.1%
0.00%
Q3 2015$110,000
-74.1%
19,076
-45.7%
0.00%
Q1 2015$425,00035,1310.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q1 2015
NameSharesValueWeighting ↓
Ayer Capital Management, LP 2,823,333$25,890,00096.51%
Avoro Capital Advisors LLC 2,923,065$26,805,0007.38%
ACUTA CAPITAL PARTNERS, LLC 886,000$8,125,0005.02%
Perceptive Advisors 2,759,593$25,305,0001.52%
Ghost Tree Capital, LLC 350,000$3,210,0001.04%
Broadfin Capital, LLC 1,812,419$16,620,0000.89%
P.A.W. CAPITAL CORP 80,000$734,0000.74%
Rhenman & Partners Asset Management AB 556,000$5,099,0000.61%
Cormorant Asset Management, LP 499,815$4,583,0000.61%
Trellus Management Company, LLC 38,500$353,0000.40%
View complete list of LION BIOTECHNOLOGIES INC shareholders